Diurnal is an innovative UK-based specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions
Diurnal is tracked in the Tech.eu funding database. Based in Cardiff, UK; active in Healthtech. Acquired by Neurocrine in 2022. Data as of 23 Aug 2026.
